PROFESSOR LUIS FERNÁNDEZ-VEGA PARTICIPATES I...
The meeting takes place on Friday 25 and Saturday 26 January at the hall “Galicia” in Santiago de Compostela.
A TEAM FROM THE FOUNDATION TRAVELS TO CAMBODI...
The group of ophthalmologists and optometrists travels to Cambodia from the 31st of October to the 11th of November to provide ophthalmological service to individuals in need.
DR ALFONSO FROM THE INSTITUTE WILL HEAD THE A...
The Chair arises with the aim of increasing the activity that has been taking on sporadically the holder of the position and to provide it with a stable framework.
THE INSTITUTE AND ALSA SING A COOPERATION AGR...
Beneficial conditions are offered to patients and staff of the Institute who use regular bus public transport; there are also beneficial conditions in eye care for the staff of the transport company.
IV OPHTHALMOLOGY CONFERENCE
The Ophthalmology Department of the Universidad de Oviedo, headed by Professor Luis Fernández-Vega, is holding the IV Ophthalmology Conference 2012 on Saturday, 27 October at 11:00 hours
PROFESSIONALS AT THE INSTITUTE PARTICIPATE AT...
The congress of the Galician Society of Clinical Optometry (SGOC, in Spanish) will be celebrated in Santiago de Compostela on the 20th and 21st October.
JOSÉ F. ALFONSO SÁNCHEZ PARTICIPATES IN THE...
It will be held on Friday 19th October in Zaragoza and participate nearly 150 specialists in ophthalmology from all over Spain .
POR PRIMERA VEZ SE IDENTIFICA EL OJO DOMINANT...
En las últimas décadas las necesidades visuales han cambiado como consecuencia de vivir en una sociedad en constante cambio con tecnologías avanzadas y nuevos aparatos electrónicos que aceleran nuestro ritmo de vida.
UNA APLICACIÓN MÓVIL SOBRE RETINOPATÍA DIA...
Novartis ha presentado, en el marco del 88 Congreso de la Sociedad Española de Oftalmología, una nueva aplicación gratuita sobre la retinopatía diabética que pretende ser una herramienta útil en la comunicación entre los doctores y sus pacientes.
IDENTIFICADO EL POSIBLE MECANISMO QUE INDUCE ...
Un estudio del Hospital Clínic de Barcelona revela el papel de la proteína MCP-1 (mediador proinflamatorio) en la destrucción de la retina de personas infectadas por el Toxoplasma gondii. Los resulatdos se han presentado en el marco del 88 Congreso